Latest Liquidity News

Omega Oil and Gas has raised A$46 million through a strongly oversubscribed institutional placement, positioning the company to advance its Canyon Project and expand its footprint in Queensland’s Taroom Trough. The capital injection will fund a 2026 drilling program and strategic partnerships amid looming east coast gas supply shortfalls.

Global Lithium Resources has sold its entire 264 million shareholding in Kairos Minerals for $7.1 million, boosting its cash reserves to $21.8 million. The company will now focus these funds on advancing its flagship Manna Lithium Project.

Prodigy Gold NL is proposing a significant 1-for-20 share consolidation aimed at streamlining its capital structure and enhancing its share price attractiveness ahead of its upcoming AGM.

HealthCo Healthcare & Wellness REIT has collected all outstanding rent from Healthscope and extended a rent deferral to support the ongoing sale process, while suspending distributions to preserve liquidity.

Peak Rare Earths Limited shares have been suspended from the ASX following court approval of a scheme of arrangement for acquisition by Shenghe Resources. The suspension precedes the expected delisting later this month.

Peak Rare Earths has secured court approval for its acquisition by Shenghe Resources, marking a pivotal moment with shares set to suspend and delist soon. Shareholders will receive $0.443 per share as the scheme moves toward completion.

Wellnex Life Limited has expanded its financing with a new A$2.5 million loan facility, enhancing its financial flexibility to support ongoing business growth and settle long-term obligations.

Equinox Resources has agreed to sell its Alturas Antimony Project in British Columbia to Maxus Mining, freeing up capital and focus for its core iron ore ambitions in Western Australia.

ASIC has imposed an interim stop order on the La Trobe Australian Credit Fund’s 12 Month Term Account due to alleged deficiencies in its Target Market Determination, pausing new investments while issues are addressed.

GR Engineering Services Limited has updated its dividend details for the first half of FY2025, declaring a fully franked dividend of 12 cents per share and setting the Dividend Reinvestment Plan price at AUD 3.897 with a 2.5% discount.

Highfield Resources has requested a voluntary suspension of its shares on the ASX to complete a capital raising, with trading expected to resume by 23 September 2025.

Neurizon Therapeutics has locked in a significant R&D tax incentive advance covering overseas and domestic development costs for its lead ALS drug candidate NUZ-001, accelerating its clinical progress with a $5.6 million rebate expected in 2025.